Dimensional Fund Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2M | Buy |
3,007,955
+323,540
| +12% | +$1.63M | ﹤0.01% | 2088 |
|
|
2025
Q1 | $17.4M | Buy |
2,684,415
+768,950
| +40% | +$4.98M | ﹤0.01% | 2005 |
|
|
2024
Q4 | $14.1M | Buy |
1,915,465
+703,360
| +58% | +$5.16M | ﹤0.01% | 2163 |
|
|
2024
Q3 | $9.08M | Buy |
1,212,105
+574,619
| +90% | +$4.3M | ﹤0.01% | 2337 |
|
|
2024
Q2 | $5.67M | Buy |
637,486
+58,360
| +10% | +$519K | ﹤0.01% | 2455 |
|
|
2024
Q1 | $5.87M | Buy |
579,126
+110,807
| +24% | +$1.12M | ﹤0.01% | 2506 |
|
|
2023
Q4 | $4.71M | Sell |
468,319
-259,296
| -36% | -$2.61M | ﹤0.01% | 2576 |
|
|
2023
Q3 | $6.82M | Sell |
727,615
-295,124
| -29% | -$2.76M | ﹤0.01% | 2421 |
|
|
2023
Q2 | $25.1M | Buy |
1,022,739
+977,639
| +2,168% | +$24M | 0.01% | 1814 |
|
|
2023
Q1 | $1.05M | Hold |
45,100
| – | – | ﹤0.01% | 2893 |
|
|
2022
Q4 | $1.14K | Hold |
45,100
| – | – | ﹤0.01% | 2867 |
|
|
2022
Q3 | $870K | Sell |
45,100
-72,279
| -62% | -$1.39M | ﹤0.01% | 2920 |
|
|
2022
Q2 | $2.99M | Sell |
117,379
-494,957
| -81% | -$12.6M | ﹤0.01% | 2615 |
|
|
2022
Q1 | $15.7M | Buy |
612,336
+291,785
| +91% | +$7.5M | ﹤0.01% | 2092 |
|
|
2021
Q4 | $13.4M | Buy |
320,551
+269,069
| +523% | +$11.3M | ﹤0.01% | 2189 |
|
|
2021
Q3 | $2.24M | Buy |
51,482
+13,793
| +37% | +$600K | ﹤0.01% | 2823 |
|
|
2021
Q2 | $1.78M | Sell |
37,689
-10,381
| -22% | -$491K | ﹤0.01% | 2896 |
|
|
2021
Q1 | $2.47M | Buy |
48,070
+38,200
| +387% | +$1.96M | ﹤0.01% | 2799 |
|
|
2020
Q4 | $264K | Buy |
9,870
+274
| +3% | +$7.33K | ﹤0.01% | 3190 |
|
|
2020
Q3 | $329K | Buy |
+9,596
| New | +$329K | ﹤0.01% | 3137 |
|